Archive: 2025/12

Foreign Manufacturing of Generics: FDA Oversight and Standards in 2025

Foreign-made generic drugs supply most of the U.S. market, but FDA oversight has been inconsistent. New unannounced inspections and stricter standards aim to close the gap-protecting patients from unsafe or ineffective medicines.